Tiered Pharmacy Copayments for Medications; Calendar Year 2026 Update

Document Headings Document headings vary by document type but may contain the following: the agency or agencies that issued and signed a document the number of the CFR title and the number of each part the document amends, proposes to amend, or is directly related to the agency docket number / agency internal file number the RIN which identifies each regulatory action listed in the Unified Agenda of Federal Regulatory and Deregulatory Actions See the Document Drafting Handbook for more details. Department of Veterans Affairs [Docket No. VA-2026-VACO-0001] AGENCY: Department of Veterans Affairs. ACTION: Notice. SUMMARY: This Department of Veterans Affairs (VA) Notice updates the information on Tier 1 Medications. FOR FURTHER INFORMATION CONTACT: Tamara Wagner, Management Analyst, Office of Finance/Revenue Operations, Veterans Health Administration, (970) 242-0731, extension 2219. SUPPLEMENTARY INFORMATION: Section 17.110 of title 38, Code of Federal Regulations (CFR), governs copayments for medications that VA provides to veterans. Section 17.110 provides the methodologies for establishing the copayment amount for each 30-day or less supply of medication provided by VA on an outpatient basis (other than medication administered during treatment). Tier 1 medication means a multi-source medication that has been identified using the process described in paragraph (b)(2) of § 17.110. Not less than once per year, VA will identify a subset of multi-source medications as Tier 1 medications. Only medications that meet all the criteria in 38 CFR 17.110(b)(2)(i) , (ii) , and (iii) will be eligible to be considered Tier 1 medications, and only those medications that meet all the criteria in paragraph (b)(2)(i) of this section will be assessed using the criteria in paragraphs (b)(2)(ii) and (iii). Based on the methodologies set forth in § 17.110, this notice updates the list of Tier 1 medications for Calendar Year 2026. The Tier 1 medication list is posted…